The need for magnetic resonance imaging (MRI) contrast agents with improved relaxivity maintains the development of new Gd-III chelates as an intensive and demanding field of research. In this work, we introduce the new dimeric chelators bis{1,4,7,10-tetraazacyclododecane-1-[(6-amino)hexanoic]- 4,7,10-triacetic acid} adipate [L2, bis(DOTA-AHA)-adipate] and bis{1,4,7,10-tetraazacyclododecane-1-[(6amino) hexanoic]-4,7,10-triacetic acid} 1,3-phenyldiacetate [L3, bis(DOTA-AHA)1,3-phenyldiacetate], which are based on the bifunctional ligand 1,4,7,10-tetraazacyclododecane-1-[(6-amino) hexanoic]-4,7,10-triacetic acid (L1, DOTA-AHA). Their Gd-III chelates were studied by variable-temperature H-1 nuclear magnetic relaxation dispersion (NMRD) and O-1...
The bifunctional chelator S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-1,4...
Paramagnetic Gd(III) chelate contrast agents have been extensively used to enhance the signal of MRI...
The bifunctional chelator S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-1,4...
The need for MRI contrast agents with improved relaxivity maintains the development of new Gd(III) c...
Three PEGylated derivatives of 1,4,7,10-tetraazacyclododecane-1-((6-amino)hexanoic)-4,7,10-triacetic...
Three PEGylated derivatives of 1,4,7,10-tetraazacyclododecane-1-((6-amino)hexanoic)-4,7,10-triacetic...
International audienceThe ligand DOTASA was designed and synthesized in the aim of obtaining a kinet...
International audience17O NMR and (1)H NMRD studies have been performed on a series of Gd(III) 1,4,7...
International audienceWe have synthesized ditopic ligands L(1), L(2), and L(3) that contain two DO3A...
International audienceWe have synthesized ditopic ligands L(1), L(2), and L(3) that contain two DO3A...
International audienceWe have synthesized ditopic ligands L(1), L(2), and L(3) that contain two DO3A...
International audienceWe have synthesized ditopic ligands L(1), L(2), and L(3) that contain two DO3A...
International audienceWe have synthesized ditopic ligands L(1), L(2), and L(3) that contain two DO3A...
The key criteria to optimize the relaxivity of a Gd(III) contrast agent at high fields (defined as t...
The bifunctional chelator S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-1,4...
The bifunctional chelator S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-1,4...
Paramagnetic Gd(III) chelate contrast agents have been extensively used to enhance the signal of MRI...
The bifunctional chelator S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-1,4...
The need for MRI contrast agents with improved relaxivity maintains the development of new Gd(III) c...
Three PEGylated derivatives of 1,4,7,10-tetraazacyclododecane-1-((6-amino)hexanoic)-4,7,10-triacetic...
Three PEGylated derivatives of 1,4,7,10-tetraazacyclododecane-1-((6-amino)hexanoic)-4,7,10-triacetic...
International audienceThe ligand DOTASA was designed and synthesized in the aim of obtaining a kinet...
International audience17O NMR and (1)H NMRD studies have been performed on a series of Gd(III) 1,4,7...
International audienceWe have synthesized ditopic ligands L(1), L(2), and L(3) that contain two DO3A...
International audienceWe have synthesized ditopic ligands L(1), L(2), and L(3) that contain two DO3A...
International audienceWe have synthesized ditopic ligands L(1), L(2), and L(3) that contain two DO3A...
International audienceWe have synthesized ditopic ligands L(1), L(2), and L(3) that contain two DO3A...
International audienceWe have synthesized ditopic ligands L(1), L(2), and L(3) that contain two DO3A...
The key criteria to optimize the relaxivity of a Gd(III) contrast agent at high fields (defined as t...
The bifunctional chelator S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-1,4...
The bifunctional chelator S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-1,4...
Paramagnetic Gd(III) chelate contrast agents have been extensively used to enhance the signal of MRI...
The bifunctional chelator S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-1,4...